Literature DB >> 7752909

Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome.

P Andersen1, I Seljeflot, M Abdelnoor, H Arnesen, P O Dale, A Løvik, K Birkeland.   

Abstract

In overweight women with polycystic ovary syndrome (PCOS), increased insulin resistance has been observed. Since abdominal obesity is associated with impaired fibrinolytic capacity and elevated levels of plasminogen activator inhibitor (PAI-1) and since PAI-1 seems to be related to insulin resistance, we investigated the possible effects of dietary intervention on lipids, fibrinolysis, coagulation, and insulin sensitivity in obese PCOS women. Nine women aged 22 to 39 years (median weight, 97 kg) ate a protein-rich very-low-calorie diet (VLCD) (Nutrilett, Nycomed Pharma, Oslo, Norway; 421 kcal/d) for 4 weeks (part 1). After significant reductions of body fat (13%, P < .01), two of nine women achieved regular menstruation and became pregnant. Six of the remaining women continued on a conventional low-calorie diet (1,000 to 1,500 kcal/d) for the next 20 weeks (part 2), during which time they were generally able to preserve the body fat loss obtained in part 1 of the study. During part 1, significant reductions of total serum cholesterol (29%, P = .001) and fasting triglyceride ([TG] 31%, P < .05) levels were observed, as well as significant reductions of fasting glucose (6%, P < .05) and insulin (20%, P < .05). Insulin sensitivity (glucose disposal rate [GDR]) was increased by 93% (P < .05). After finishing part 2, insulin sensitivity was still significantly increased (86%, P < .05) and PAI-1 activity was significantly reduced (54%, P < .05). Moreover, overall fibrinolytic activity was significantly improved (serum D-dimer concentration increased by 75%, P < .05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7752909     DOI: 10.1016/0026-0495(95)90118-3

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  13 in total

Review 1.  How actual is the dietary treatment in overweighting patients with polycystic ovary syndrome?

Authors:  C Cortet-Rudelli; D Dewailly
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

2.  The effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study.

Authors:  Sedigheh Ghandi; Abbas Aflatoonian; Nasim Tabibnejad; Mohammad Hossein Sojoodi Moghaddam
Journal:  J Assist Reprod Genet       Date:  2011-04-12       Impact factor: 3.412

3.  Role of diet in the treatment of polycystic ovary syndrome.

Authors:  Crystal C Douglas; Barbara A Gower; Betty E Darnell; Fernando Ovalle; Robert A Oster; Ricardo Azziz
Journal:  Fertil Steril       Date:  2006-03       Impact factor: 7.329

Review 4.  Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility.

Authors:  Dimitrios Panidis; Konstantinos Tziomalos; Efstathios Papadakis; Christos Vosnakis; Panagiotis Chatzis; Ilias Katsikis
Journal:  Endocrine       Date:  2013-04-27       Impact factor: 3.633

5.  Diet-induced obesity exacerbates metabolic and behavioral effects of polycystic ovary syndrome in a rodent model.

Authors:  Ilana B Ressler; Bernadette E Grayson; Yvonne M Ulrich-Lai; Randy J Seeley
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-04-14       Impact factor: 4.310

6.  Fetal programming of adult hypertension in female rat offspring exposed to androgens in utero.

Authors:  K Sathishkumar; Rebekah Elkins; Uma Yallampalli; Meena Balakrishnan; Chandrasekhar Yallampalli
Journal:  Early Hum Dev       Date:  2011-03-29       Impact factor: 2.079

7.  The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.

Authors:  S Jafari-Sfidvajani; R Ahangari; M Hozoori; H Mozaffari-Khosravi; H Fallahzadeh; A Nadjarzadeh
Journal:  J Endocrinol Invest       Date:  2017-11-06       Impact factor: 4.256

Review 8.  Longterm management of Polycystic Ovarian Syndrome (PCOS).

Authors:  Gordon W Bates; Richard S Legro
Journal:  Mol Cell Endocrinol       Date:  2012-12-20       Impact factor: 4.102

9.  High-Fat, High-Sugar Diet Disrupts the Preovulatory Hormone Surge and Induces Cystic Ovaries in Cycling Female Rats.

Authors:  Katrina M Volk; Veronika V Pogrebna; Jackson A Roberts; Jennifer E Zachry; Sarah N Blythe; Natalia Toporikova
Journal:  J Endocr Soc       Date:  2017-11-02

Review 10.  Cardiometabolic aspects of polycystic ovarian syndrome.

Authors:  Li Wei Cho; Harpal S Randeva; Stephen L Atkin
Journal:  Vasc Health Risk Manag       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.